insiderdelta
CoverageForm 410-K10-Q8-K13D13G13F

KIDS Orthopediatrics Corp - 8-K

Filed Jun 4, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0001425450-26-000041
5.07

Item 5.07 - Submission of Matters to a Vote of Security Holders

306 words

Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 4, 2026, OrthoPediatrics Corp. (the "Company") held its 2026 Annual Meeting of Stockholders and the Company's stockholders voted on the following matters:

Election of Directors

The nominees below were elected to serve as directors for a term that will last until the Company’s 2029 Annual Meeting of Stockholders or until his or her successor is duly elected and qualified.  The number of votes cast for and withheld from each nominee and the number of broker non-votes with respect to each nominee were as follows:

Name

Votes For

Votes Withheld

Broker Non-Votes

George S. M. Dyer

10,843,747

8,009,267

1,827,535

Kelly Fischer

18,535,024

317,990

1,827,535

David R. Pelizzon

18,056,773

796,241

1,827,535

Harald Ruf

18,077,260

775,754

1,827,535

Approval, on an advisory basis, of the compensation of the Company's named executive officers

The Company's stockholders approved the compensation of the Company's named executive officers by voting as follows:

For

Against

Abstain

Broker Non-Votes

15,953,457

2,859,793

39,764

1,827,535

Approval, of an amendment to the 2024 Incentive Award Plan ("Plan") to increase the number of shares authorized under the Plan by 2,050,000 shares, which would increase the total number of shares to 3,679,000

The Company's stockholders approved the amendment to the 2024 Incentive Award Plan by voting as follows:

For

Against

Abstain

Broker Non-Votes

18,545,409

272,115

35,490

1,827,535

Approval, on an advisory basis, of the appointment of Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm for our Fiscal Year Ending December 31, 2026

The Company’s stockholders approved the appointment by the Audit Committee of the Company’s Board of Directors of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 by voting as follows:

For

Against

Abstain

20,479,183

154,131

47,235

* * * * * *